Written in by SCOLI
The University of Pittsburgh has been awarded a prestigious NIH R21 exploratory/development grant totaling $414,000 over two years to develop groundbreaking wireless metamaterial technology for monitoring spinal fusion healing in real-time.
The project, titled “Wireless Metamaterial Interbody Cage for Real-Time Assessment of Lumbar Spinal Fusion In Vivo,” represents a significant advancement in neurosurgical implant technology and patient care.
The Research Team
The interdisciplinary research team is led by principal investigators Dr. Amir H. Alavi, PhD, and Dr. Nitin Agarwal, MD, with Dr. D. Kojo Hamilton, MD serving as co-investigator. The team combines expertise in advanced materials engineering and neurological spine surgery. Dr. Alavi brings his pioneering work in mechanical metamaterials and energy harvesting technologies, while both Drs. Agarwal and Hamilton contribute extensive clinical experience as neurological spine surgeons at UPMC along with additional research leadership to the collaborative effort.
“We are very excited as this will be the first time we examine how our electronics-free metamaterial interbody implants transmit force signals wirelessly in vivo. We have demonstrated the concept in vitro using cadaveric spine models, but in vivo validation is the key step toward clinical translation. Our team brings together complementary strengths in materials science, sensing, and neurosurgery, which makes it possible to move this technology closer to patient impact.”
— Dr. Amir H. Alavi, MPI
“A connected healthcare experience via implants that can communicate in a wireless fashion is the next frontier for patient care for spinal disorders. This technology will allow real-time data for both patients and providers.”
— Dr. Nitin Agarwal, MPI
Addressing a Critical Clinical Need
Current methods for assessing spinal fusion rely primarily on radiographic imaging, which has significant limitations including poor specificity and sensitivity, radiation exposure, and dependence on patient cooperation. These conventional approaches provide only “snapshots in time” rather than continuous monitoring of the fusion process, making it difficult for clinicians to accurately assess healing progress and detect potential complications early.
The research addresses several critical unmet needs:
- Continuous monitoring of fusion progress without radiation exposure
- Early detection of hardware failure to prevent neurological injury
- Objective assessment of when patients can safely return to normal activities
- Elimination of imaging quality issues and patient cooperation dependencies
Revolutionary Metamaterial Technology
The team’s innovative approach centers on developing the first-of-its-kind personalized, electronic-free, wireless metamaterial interbody fusion cage. This breakthrough technology is built on the concept of “meta-mechanotronics” – the integration of mechanical metamaterials with nano energy harvesting capabilities.
Key Technical Innovations
Self-Powered Operation: The metamaterial cage generates electrical signals through contact electrification when subjected to spine micro-motions, functioning as a triboelectric nanogenerator (TENG) without requiring external power sources.
Wireless Signal Transmission: The strain-induced electric field created by the implant can propagate through body tissue and be detected wirelessly using electrodes placed on the skin, potentially even with commercially available ECG monitors.
Mechanical Tunability: The metamaterial structure can be customized to match individual patient anatomy and bone density through “rationally designed” unit cells that constitute the metamaterial lattice.
Real-Time Monitoring: As bone fusion progresses and load transfers from the implant to the fused vertebrae, the electrical signal decreases proportionally, providing continuous feedback on healing status.
Research Approach
The two-year project follows a systematic development and validation strategy designed to advance the technology toward clinical application:
Phase 1: Development and characterization of the metamaterial fusion monitoring system, including comprehensive testing of electrical properties, mechanical durability, and biocompatibility standards required for implantable devices.
Phase 2: Preclinical validation studies using established animal models to evaluate the wireless monitoring capabilities and assess fusion progression over multiple time points.
The research methodology incorporates industry-standard testing protocols and follows established preclinical pathways for medical device development, ensuring rigorous validation of the technology’s safety and efficacy.
Preliminary Results
The research team has already demonstrated promising proof-of-concept results:
- Successfully showed that metamaterial cages can generate electrical signals proportional to spinal loads in human cadaver models
- Demonstrated wireless signal transmission through simulated body fluid and porcine tissue
- Achieved power outputs of 45 nanowatts with prototype cages – significantly higher than the picowatt levels needed for signal transmission
- Validated that signals can be detected at distances up to 15 cm under physiological loading conditions
Clinical Impact and Future Implications
This technology has the potential to transform spinal fusion care by:
Improving Patient Safety: Continuous monitoring enables early detection of hardware failure and potential neurological complications.
Optimizing Recovery: Objective data on fusion progress allows for more precise determination of when patients can safely return to normal activities, potentially reducing unnecessary activity restrictions.
Reducing Healthcare Costs: Eliminating the need for frequent radiographic follow-ups reduces radiation exposure and healthcare expenses.
Enhancing Clinical Decision-Making: Real-time fusion data provides clinicians with unprecedented insights into the healing process, enabling more informed treatment decisions.
Building on Previous Success
This R21 award builds upon the team’s ongoing NIH Trailblazer project (1R21EB034457-01A1), which focuses on developing computational tools for mechanically tuned metamaterial fusion cages. The new award specifically advances the sensing and wireless communication capabilities, representing the next critical step toward clinical translation.
Looking Forward
The successful completion of this R21 project will establish a preclinical basis for future larger animal studies and eventual human clinical trials. The research represents a paradigm shift from traditional passive implants to intelligent, self-monitoring devices that provide continuous feedback on healing progress.
The award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) reflects the high potential impact of this technology and the NIH’s commitment to supporting innovative approaches to musculoskeletal health challenges.
This groundbreaking research positions the University of Pittsburgh at the forefront of smart biomedical implant technology and demonstrates the power of interdisciplinary collaboration in addressing complex clinical challenges. As the technology advances toward clinical application, it promises to significantly improve outcomes for the thousands of patients who undergo spinal fusion procedures each year.
The research described is supported by NIH/NIAMS grant R21AR085218. The content represents the work of the research team and does not necessarily reflect the official views of the National Institutes of Health.
Share this article:
Published
Posted by
SCOLI
